MariMed Inc. (MRMD)

0,2585 +0,0023 (+0,88%) Börsenschluss: 03:59PM EDT

MariMed Inc.

10 Oceana Way
Norwood, MA 02062
United States
781 277 0007
https://www.marimedinc.com

Sektor(en): Healthcare
Branche: Drug Manufacturers - Specialty & Generic
Vollzeitmitarbeiter: 643

Leitende Angestellte

Name	Titel	Zahlen	Ausgeübt	Geburtsjahr
Mr. Jon R. Levine	Co-Founder, CEO, Interim CFO, President, Secretary, Treasurer & Director	481,74k	N/A	1965
Mr. Timothy Shaw	Chief Operating Officer	445,86k	N/A	1978
Mr. Jonathan W. Rider	Chief Information Officer	N/A	N/A	1965
Mr. Steve Wayne West	Vice President of Investor Relations	N/A	N/A	N/A
Mr. Howard Schacter	Chief Communications Officer	N/A	N/A	N/A
Ms. Sara Gullickson	Vice President of Marketing	N/A	N/A	1985
Mr. Ryan Crandall	Chief Revenue Officer	N/A	N/A	N/A
Mr. Charles Holt Finnie	Chief Strategy Officer	N/A	N/A	N/A

Die Beträge haben den Stand 31. Dezember 2022 und Kompensationswerte gelten für das letzte Geschäftsjahr bis zu diesem Datum. Der Lohn umfasst Gehalt, Boni usw. „Ausgeübt“ entspricht dem Wert von Optionen, die im Lauf des Geschäftsjahrs ausgeübt werden. Währung in USD.

Beschreibung

MariMed Inc. engages in cultivation, production, and dispensing of medicinal and recreational cannabis in the United States and internationally. The company sells flowers and concentrates under the Nature's Heritage brand; and soft and chewy baked goods and a hot chocolate mix under Bubby's Baked brand; and drink mix under Vibations brand. It also offers chewable cannabis-infused mint tablet under the brand Kalm Fusion; and flower, vapes, and edibles under InHouse brand. In addition, the company provides supplement, nutrient-infused fruit chews under Betty's Eddies brand and ice creams under Emack & Bolio's brand. The company licenses its brands. MariMed Inc. was incorporated in 2011 and is based in Norwood, Massachusetts.

Corporate Governance

MariMed Inc.s ISS Governance QualityScore, Stand N/A, lautet N/A. Die grundlegenden Scores sind Audit: N/A, Vorstand: N/A, Shareholderrechte: N/A, Kompensation: N/A.

Corporate-Governance-Bewertungen von Institutional Shareholder Services (ISS). Die Werte geben den Zehntelwert im Verhältnis zum Index oder zur Region an. Ein Zehntelwert von 1 zeigt geringeres Governance-Risiko, 10 höheres Governance-Risiko.